Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Anthem Biosciences Limited (NSE: ANTHEM), ISIN INE0CZ201020 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
ANTHEM last traded at ₹958.55 (+4.70%), with a 52-week range of ₹579.15 to ₹989.10 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 71.40%, FIIs 3.79%, DIIs 12.10%, mutual funds 9.25%.
EquiSense Score (ECS): 71/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.